- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 16.67M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 19.31M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 11.11M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.92M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $16.07M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $16.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $14.49M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $18.56M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.64M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.27M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $17.43M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $19.07M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.43M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $19.07M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.40 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.40 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.23M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.37M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.84M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.14M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.18M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.45M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.07M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.96M |